User Name:

Password:

remember me

Forgot your password?

Not a member?

Join Now

Press Releases

RSS feedDisplaying articles 1 - 10 of most recent articles

Photo from PR Newswire
Le HiPhi X de Human Horizons s'est retrouv en tte des ventes des vhicules lectriques de luxe en Chine au second semestre de 2021 SHANGHAI, 18 janvier 2022 /PRNewswire/ -- Selon les donnes publies par le China Automotive Technology & Research Center, le HiPhi X a t le vhicule le plus vendu dans la catgorie des vhicules de luxe lectrique dont le prix de vente conseill est de plus de
PR Newswire | 26 minutes ago | comment? | recommend
DEL TACO INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed NEW ORLEANS, Jan. 18, 2022 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of Del Taco Restaurants, Inc. (NasdaqCM: TACO) to Jack in the
PR Newswire | 31 minutes ago | comment? | recommend
Nobu Hospitality ouvre un htel-restaurant sur la magnifique le Santorin, en Grce NEW YORK, 19 janvier 2022 /PRNewswire/ -- Nobu Hospitality, la marque de lifestyle internationale fonde par Nobu Matsuhisa, Robert De Niro et Meir Tepern, annonce l'ouverture de son premier htel-restaurant en Grce, le Nobu Hotel and Restaurant Santorini,
PR Newswire | 34 minutes ago | comment? | recommend
Darktrace Firma Acuerdo Multimillonario Con Importante Aerolnea Global CAMBRIDGE, Inglaterra, 18 de enero de 2022 /PRNewswire/ -- Darktrace, lder global en IA de ciberseguridad, anunci hoy que una de las aerolneas ms grandes del mundo firm una importante renovacin de acuerdo con Darktrace y seguir utilizando la tecnologa de
PR Newswire | 36 minutes ago | comment? | recommend
CStone announces the GEMSTONE-302 study of sugemalimab met the endpoint of overall survival in the first-line treatment of metastatic non-small cell l Sugemalimab is the world's first PD-L1 monoclonal antibody that when administered along with chemotherapy improved overall survival of first-line metastatic squamous and non-squamous non-small cell lung cancer patients in a statistically significant and c
PR Newswire | 41 minutes ago | comment? | recommend
Transplant Connect to Expand Human Biologics Management Software with Investment from InVita Healthcare Technologies LOS ANGELES, Jan. 18, 2022 /PRNewswire/ -- Transplant Connect, the world's leading software provider for the donation and transplantation field, is pleased to announce an investment from InVita Healthcare Technologies. InVita provides leading chain of cus
PR Newswire | 44 minutes ago | comment? | recommend
Photo from PR Newswire
AnDAPT Introduces Power Solutions for Microchip PolarFire FPGAs DUBLIN, Jan. 18, 2022 /PRNewswire/ -- AnDAPT- the power supply specialists for FPGAs/SoCs, today launched power management solution PMICs for Microchip PolarFire FPGAs (Table 1). This follows-up on AnDAPT's previous announcement of programmable power supp
PR Newswire | 45 minutes ago | comment? | recommend
Photo from PR Newswire
Bonne nouvelle pour les amateurs de kung-fu du monde entier - le Temple de Shaolin lance des jeux de kung-fu en ligne DENGFENG, Chine, 18 janvier 2022 /PRNewswire/ -- Avec le Nouvel An chinois qui approche grands pas, le Temple de Shaolin de Songshan en Chine et les centres culturels Shaolin du monde entier ont lanc un concours mondial de kung-fu - Bon Nouvel An chinois
PR Newswire | 47 minutes ago | comment? | recommend
Photo from PR Newswire
Brown Gibbons Lang & Company Promotes Three to Managing Director CLEVELAND and CHICAGO, Jan. 18, 2022 /PRNewswire/ -- Brown Gibbons Lang & Company (BGL), a leading independent investment bank and financial advisory firm, is pleased to announce the promotion of J. Kyle Brown, Kevin H. Sargent, and Michael T. Vinciguerra
PR Newswire | 59 minutes ago | comment? | recommend
Serie-A-Runde ber 15 Mio. USD: Dermaliq Therapeutics unterzeichnet Finanzierungsrunde fr klinische Studien dreier transformativer Arzneimitteltherapie - Dermaliq Therapeutics, Inc. ist ein unabhngiges privates Pharmaunternehmen, das aus Novaliq hervorgegangen ist - Ausgrndung zur Wertschpfung im Bereich der medizinischen Dermatologie durch Einsatz der transformativen Technologie von Novaliq auerhalb der
PR Newswire | 1 hour, 6 minutes ago | comment? | recommend